Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant arterivirus replicon systems and uses thereof

Recombinant arterivirus replicon systems and uses thereof

US Patent 11555205 · Granted Jan 17, 2023

Estimated economic value: $437,156,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant arterivirus replicon systems and uses thereof2025
Recombinant arterivirus replicon systems and uses thereof2025
Recombinant arterivirus replicon systems and uses thereof2025
Recombinant arterivirus replicon systems and uses thereof2025
Alphavirus-based replicons for administration of biotherapeutics2025
Alphavirus-based replicons for administration of biotherapeutics2025
Nanolipoprotein particles and related compositions methods and systems for loadi2024
Nanolipoprotein particles and related compositions methods and systems for loadi2024
Nanolipoprotein particles and related compositions methods and systems for loadi2024
Compositions and methods for expression of IL-12 and IL-1RA2024
Compositions and methods for enhancing gene expression2023
Compositions and methods for enhancing gene expression2023